DEEPAKNTR NSE filing

Deepak Nitrite Subsidiary Invests ₹100 Crore in Deepak Chem Tech

The RealCase readLow impact Neutral

Deepak Chem Tech Limited, a subsidiary of Deepak Nitrite Limited, has issued and allotted ₹100 Crores in 9% Optionally Convertible Redeemable Preference Shares to another subsidiary, Deepak Phenolics Limited. The funds will strengthen DCTL's capital base and support project expenses and general corporate purposes.

Why it matters

The investment is an internal transaction between subsidiaries to strengthen capital and support ongoing projects. While it facilitates business operations, it does not represent a significant external investment, new order, or a strategic shift that would materially impact the company's market position or financials in the short term.

The market read

The announcement details an internal fund infusion between subsidiaries, which is a standard corporate action and does not inherently indicate a positive or negative development for the company's overall financial performance.

Deepak Nitrite Limited announced that its wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL), has issued and allotted 1,00,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) with a face value of ₹100 each, aggregating to ₹100.00 Crores. This investment was made by Deepak Phenolics Limited (DPL), another wholly-owned subsidiary of Deepak Nitrite Limited.

The funds infused into DCTL are intended to strengthen its capital base and support project expenses and general corporate purposes. DCTL is engaged in the chemical industry, currently operating a state-of-the-art fluorination plant and pursuing projects across various sites in Gujarat. DCTL's turnover for FY 2024-25 was ₹9.43 Crores, and for FY 2023-24, it was ₹0.86 Crores.

This transaction is considered a Related Party Transaction as both DCTL and DPL are wholly-owned subsidiaries of Deepak Nitrite Limited. The allotment of OCRPS was made at par, i.e., ₹100 each, aggregating to ₹100.00 Crores, and is conducted on an arms-length basis. No governmental or regulatory approvals were required for this investment, and the funds were transferred via normal banking channels.

Filing to action

What to do with a filing like this

Deepak Nitrite Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Deepak Nitrite Limited. Read the original for the full detail.

View original filing